(Q51974947)

English

Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle.

scientific article published on 17 October 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17940552

Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17940552

0 references

menstrual cycle

1 reference

based on heuristic

inferred from title

Inger Sundström-Poromaa

5

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17940552

Torbjörn C. Bäckström

3

object named as

Torbjörn Bäckström

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17940552

author name string

Kristiina Kask

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17940552

Maria Gulinello

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17940552

Mark A Geyer

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17940552

language of work or name

0 references

publication date

17 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17940552

Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17940552

33

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17940552

9

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17940552

2283-2290

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17940552

The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Affective startle modulation in clinical depression: preliminary findings.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

The role of hormones and hormonal treatments in premenstrual syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Anxiolytic effects of 3α-hydroxy-5α[β]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Sensorimotor gating and dopamine function in postpartum rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Neurochemical modulation of sensory-motor reactivity: acoustic and tactile startle reflexes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Neurotransmission in the rat amygdala related to fear and anxiety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: a possible rat model of PMS anxiety.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Estrogen prevents 5-HT1A receptor-induced disruptions of prepulse inhibition in healthy women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Estrogen and progesterone prevent disruption of prepulse inhibition by the serotonin-1A receptor agonist 8-hydroxy-2-dipropylaminotetralin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Sex differences in anxiety, sensorimotor gating and expression of the alpha4 subunit of the GABAA receptor in the amygdala after progesterone withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Anxiogenic effects of neurosteroid exposure: sex differences and altered GABAA receptor pharmacology in adult rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Hippocampal alpha5 subunit-containing GABAA receptors modulate the expression of prepulse inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Menstrual cycle phase effects on prepulse inhibition of acoustic startle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

The neurobiology of startle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Interaction between 3 alpha-hydroxy-5 alpha-pregnan-20-one and carbachol in the control of neuronal excitability in hippocampal slices of female rats in defined phases of the oestrus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Prepulse inhibition deficits in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Progesterone withdrawal I: pro-convulsant effects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Amygdala and anterior cingulate cortex activation during affective startle modulation: a PET study of fear

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Difference in anxiety and sensitization of the acoustic startle response between the two inbred mouse strains BALB/cAN and DBA/2N.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Lack of effect of induced menses on symptoms in women with premenstrual syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

The acoustic startle response in inbred Roman high- and low-avoidance rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Behavioural and hormonal differences between two Lewis rat lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Men are more inhibited than women by weak prepulses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Pharmacokinetic and behavioral effects of allopregnanolone in healthy women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Progesterone attenuates corticotropin-releasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Effects of ovariectomy and estradiol on acoustic startle responses in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

Estrogen increases prepulse inhibition of acoustic startle in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

The effects of allopregnanolone, pregnenolone sulphate and pregnenolone on the CA1 population spike of the rat hippocampus after 17 beta-oestradiol priming.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

21 January 2018

The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

7 January 2021

based on heuristic

inferred from DOI database lookup

Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclical mood changes as in the Premenstrual tension Syndrome during Sequential Estrogen-Progestagen Postmenopausal Replacement Therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between symptom severity and hormone changes in women with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

7 January 2021

based on heuristic

inferred from DOI database lookup

Exaggerated acoustic startle reflex in Gulf War veterans with posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

7 January 2021

based on heuristic

inferred from DOI database lookup

Withdrawal from 3alpha-OH-5alpha-pregnan-20-One using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxiety.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

7 January 2021

based on heuristic

inferred from DOI database lookup

Lactation-induced reduction in rats' acoustic startle is associated with changes in noradrenergic neurotransmission.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301599

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1301599

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17940552

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/17940552

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51974947&oldid=2211376323"